TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $108,397 | -83.3% | 6,900 | -82.5% | 0.06% | -84.4% |
| Q1 2023 | $650,310 | +5.6% | 39,461 | 0.0% | 0.40% | -8.9% |
| Q4 2022 | $615,598 | +20.2% | 39,461 | -0.0% | 0.44% | +2.6% |
| Q3 2022 | $512,000 | +8.9% | 39,464 | +18.0% | 0.43% | +15.1% |
| Q2 2022 | $470,000 | -1.7% | 33,450 | +0.2% | 0.37% | +18.2% |
| Q1 2022 | $478,000 | +25.1% | 33,378 | +19.1% | 0.31% | +29.3% |
| Q4 2021 | $382,000 | – | 28,025 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |